Evaluation of the mood-stabilizing agent valproic acid as a preventative for toxoplasmosis in mice and activity against tissue cysts in mice

Journal of Parasitology

Volumn 94, Issue 2, 2008, Pages 555-557

  Goodwin, David G ^a   Strobl, Jeannine ^b   Mitchell, Sheila M ^a   Zajac, Anne M ^a   Lindsay, David S ^a  

^a VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

^b EDWARD VIA COLLEGE OF OSTEOPATHIC MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRINKING WATER; MOOD STABILIZER; VALPROIC ACID;

DISEASE CONTROL; DRINKING WATER; DRUG; EXPERIMENTAL STUDY; HEARING; INFECTIOUS DISEASE; INHIBITION; INOCULATION; PARASITIC DISEASE; PREGNANCY; PROTOZOAN; RODENT; VISION;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYST; DRUG ACTIVITY; EVALUATION; FEMALE; IN VITRO STUDY; IN VIVO STUDY; INOCULATION; MOUSE; NONHUMAN; STATISTICAL SIGNIFICANCE; TACHYZOITE; TOXOPLASMA GONDII; TOXOPLASMOSIS; WEIGHT;

ADMINISTRATION, ORAL; ANIMALS; ANTIMANIC AGENTS; FEMALE; INJECTIONS, INTRAPERITONEAL; MICE; MICE, INBRED ICR; TOXOPLASMA; TOXOPLASMOSIS, ANIMAL; TREATMENT FAILURE; VALPROIC ACID;

MUS; PROTOZOA; RATTUS; TOXOPLASMA GONDII;

EID: 43949147238     PISSN: 00223395     EISSN: None     Source Type: Journal    
DOI: 10.1645/GE-1331.1     Document Type: Article

References (16)

1. BACHMANN, S., J. SCHRODER, C. BOTTMER, E. F. TORREY, AND R. H. YOLKEN. 2005. Psychopathology in first-episode schizophrenia and antibodies to Toxoplasma gondii. Psychopathology 38: 87-90.
2. BERDOY, M., J. P. WEBSTER, AND D. W. MACDONALD. 2000. Fatal attraction in rats infected with Toxoplasma gondii. Proceedings of the Royal Society B 267: 1591-1594.
3. BOWDEN, C. L. 2007. Spectrum of effectiveness of valproate in neuropsychiatry. Expert Reviews in Neurotherapy 7: 9-16.
4. BROWN, A. S., C. A. SCHAEFER, C. P. QUESENBERRY, JR., L. LIU, V. P. BABULAS, AND E. S. SUSSER. 2005. Maternal exposure to toxoplasmosis and risk of schizophrenia in adult offspring. American Journal of Psychiatry 162: 767-773.
5. HOLLIMAN, R. E. 1997. Toxoplasmosis, behaviour and personality. Journal of Infection 35: 105-110.
6. JONES, J. L., A. LOPEZ, M. WILSON, J. SCHULKIN, AND R. GIBBS. 2001. Congenital toxoplasmosis: A review. Obstetrical and Gynecological Survey 56: 296-305.
7. _, D. KRUSZON-MORAN, M. WILSON, G. MCQUILLAN, T. NAVIN, AND J. B. MCAULEY. 2001. Toxoplasma gondii infection in the United States: Seroprevalence and risk factors. American Journal of Epidemiology 154: 357-365.
8. JONES-BRANDO, L., E. F. TORREY, AND R. H. YOLKEN. 2003. Drugs used in the treatment of schizophrenia and bipolar disorder inhibit the replication of Toxoplasma gondii. Schizophrenia Research 62: 237-244.
9. LEDGERWOOD, L. G., P. W. EWALD, AND G. M. COCHRAN. 2003. Genes, germs, and schizophrenia: An evolutionary perspective. Perspectives in Biological Medicine 46: 317-348.
10. STROBL, J. S., M. CASSELL, S. M. MITCHELL, C. M. REILLY, AND D. S. LINDSAY. 2007. Scriptaid and suberoylanilide hydroxamic acid are histone deacetylase inhibitors with potent anti-Toxoplasma activity in vitro. Journal of Parasitology 93: 694-700
11. TORREY, E. E., AND R. H. YOLKEN. 2003. Toxoplasma gondii and schizophrenia. Emerging Infectious Diseases 9: 1375-1380.
12. VYAS, A., S. K. KIM, N. GIACOMINI, J. C. BOOTHROYD, AND R. M. SAPOLSKY. 2007. Behavioral changes induced by Toxoplasma infection of rodents are highly specific to aversion of cat odors. Proceedings of the National Academy of Sciences of the United States of America 104: 6442-6447.
13. WANG, H. L., G. H. WANG, Q. Y. LI, C. SHU, M. S. JIANG, AND Y. GUO. 2006. Prevalence of Toxoplasma infection in first-episode schizophrenia and comparison between Toxoplasma-seropositive and Toxoplasma-seronegative schizophrenia. Acta Psychiatrica Scandinavica 114: 40-48.
14. WEBSTER, J. P. 2001. Rats, cats, people and parasites: The impact of latent toxoplasmosis on behaviour. Microbes and Infection. 3: 1037-1045.
15. _, P. H. LAMBERTON, C. A. DONNELLY, AND E. F. TORREY. 2006. Parasites as causative agents of human affective disorders? The impact of anti-psychotic, mood-stabilizer and anti-parasite medication on Toxoplasma gondii's ability to alter host behaviour. Proceedings of the Biological Society B 273: 1023-1030.
16. YOLKEN, R. H., S. BACHMANN, I. RUSLANOVA, E. LILLEHOJ, G. FORD, E. F. TORREY, AND J. SCHROEDER. 2001. Antibodies to Toxoplasma gondii in individuals with first-episode schizophrenia. Clinical Infectious Diseases 32: 842-844.